Frank Takkinen
Stock Analyst at Lake Street
(0.81)
# 3,899
Out of 4,944 analysts
60
Total ratings
25%
Success rate
-18.86%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Upgrades: Buy | $3 → $5 | $4.25 | +17.65% | 5 | Aug 8, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $87.36 | +71.70% | 2 | Aug 5, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $12 → $8 | $1.54 | +419.48% | 2 | Jul 31, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $9.06 | +164.90% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $15.10 | +98.68% | 1 | Jun 12, 2025 | |
| ELUT Elutia | Maintains: Buy | $10 → $8 | $2.16 | +270.37% | 3 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.98 | +152.53% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $7.73 | +81.11% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $12.76 | +17.55% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $1.27 | +18.11% | 1 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $14.76 | +103.25% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $13.99 | +85.85% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $11.92 | +151.68% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $4.30 | +16.28% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.06 | +392.61% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.50 | +100.00% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.47 | +446.08% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $43.73 | -31.40% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.51 | +297.35% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.70 | +48.15% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $9.32 | +28.76% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.36 | +281.36% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.35 | +1,085.19% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.46 | +1,906.52% | 2 | Jan 18, 2023 |
Sight Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $3 → $5
Current: $4.25
Upside: +17.65%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $87.36
Upside: +71.70%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $1.54
Upside: +419.48%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $9.06
Upside: +164.90%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $15.10
Upside: +98.68%
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.16
Upside: +270.37%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.98
Upside: +152.53%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.73
Upside: +81.11%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.76
Upside: +17.55%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $1.27
Upside: +18.11%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $14.76
Upside: +103.25%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $13.99
Upside: +85.85%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $11.92
Upside: +151.68%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $4.30
Upside: +16.28%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.06
Upside: +392.61%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.47
Upside: +446.08%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $43.73
Upside: -31.40%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.51
Upside: +297.35%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.70
Upside: +48.15%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $9.32
Upside: +28.76%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $2.36
Upside: +281.36%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.35
Upside: +1,085.19%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.46
Upside: +1,906.52%